Hopital universitaire Necker-Enfants malades, Paris, Île-de-France, France.
Hopital universitaire Necker-Enfants malades, Paris, Île-de-France, France
Eur J Hosp Pharm. 2022 Nov;29(6):353-358. doi: 10.1136/ejhpharm-2020-002620. Epub 2021 Mar 3.
To determine the physicochemical stability of pemetrexed diarginine in original vials, and after dilution in two commonly used infusion fluids (0.9% sodium chloride, 5% dextrose) in polyolefin bags, stored under refrigeration (2-8°C) or at ambient temperature (22-25°C) exposed to light.
Stability of pemetrexed diarginine injection concentrate was determined in the original glass vials with closed-system transfer device. Diluted pemetrexed diarginine infusion solutions were aseptically prepared by dilution of pemetrexed diarginine concentrate with either 0.9% sodium chloride or dextrose 5% in polyolefin bags, in amounts yielding pemetrexed diarginine concentrations of 4, 9 and 12 mg/mL. Test solutions were stored under refrigeration (2-8°C) or at ambient temperature (22-25°C) exposed to light. Pemetrexed diarginine concentrations were determined throughout a 14-day storage period using a stability-indicating HPLC assay. In addition, test solutions were visually examined for colour change and precipitation.
Pemetrexed diarginine injection concentrate with closed-system transfer device is shown to be physicochemically stable for up to 4 days when stored under refrigeration and for 1 day at room temperature. A browning of the pemetrexed diarginine concentrate solutions appeared 0n day 2 when stored at ambient temperature and on day 5 under refrigeration. Pemetrexed diarginine diluted in dextrose 5% and 0.9% sodium chloride was physicochemically stable for up to 4 days when stored under refrigeration and for 1 day at room temperature. A browning of the diluted solutions appeared on day 2 when stored at room temperature and on day 5 when stored under refrigeration.
Pemetrexed diarginine concentrate for solution stored under refrigeration with closed-system transfer device can be retained as a residual to reduce product losses. The analytical stability of pemetrexed diarginine in dextrose 5% and 0.9% sodium chloride under refrigeration enables our centralised unit to prepare this drug in advance.
确定培美曲塞二聚精氨酸在原始小瓶中的物理化学稳定性,以及在两种常用的输注液(聚烯烃袋中的 0.9%氯化钠和 5%葡萄糖)稀释后,在冷藏(2-8°C)或室温(22-25°C)下暴露于光线下的稳定性。
通过使用封闭系统转移装置在原始玻璃小瓶中确定培美曲塞二聚精氨酸注射液的稳定性。通过在聚烯烃袋中将培美曲塞二聚精氨酸浓缩物分别用 0.9%氯化钠或 5%葡萄糖稀释,制备出培美曲塞二聚精氨酸浓度为 4、9 和 12mg/mL 的稀释培美曲塞二聚精氨酸输注溶液。将测试溶液在冷藏(2-8°C)或室温(22-25°C)下暴露于光线下储存。在 14 天的储存期内,使用稳定指示 HPLC 测定法测定培美曲塞二聚精氨酸的浓度。此外,还对测试溶液的颜色变化和沉淀进行了目视检查。
当在冷藏下储存时,带有封闭系统转移装置的培美曲塞二聚精氨酸注射液在 4 天内表现出物理化学稳定性,在室温下储存 1 天。当在室温下储存时,培美曲塞二聚精氨酸浓缩物溶液在第 2 天出现棕色,在冷藏下储存时则在第 5 天出现棕色。当在冷藏下储存时,培美曲塞二聚精氨酸在 5%葡萄糖和 0.9%氯化钠中的稀释液在 4 天内表现出物理化学稳定性,在室温下储存 1 天。当在室温下储存时,稀释溶液在第 2 天出现棕色,在冷藏下储存时则在第 5 天出现棕色。
带有封闭系统转移装置的冷藏培美曲塞二聚精氨酸浓缩液可作为残留液保留,以减少产品损失。培美曲塞二聚精氨酸在 5%葡萄糖和 0.9%氯化钠中的分析稳定性使我们的中央单位能够提前制备这种药物。